comparemela.com

Page 8 - Human Albumin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Grifols, S A (NASDAQ:GRFS) Short Interest Down 10 3% in May

Grifols, S.A. (NASDAQ:GRFS – Get Rating) saw a large decrease in short interest in May. As of May 31st, there was short interest totalling 5,140,000 shares, a decrease of 10.3% from the May 15th total of 5,730,000 shares. Currently, 2.0% of the shares of the company are sold short. Based on an average daily trading […]

Grifols, S A (NASDAQ:GRFS) Short Interest Update

Grifols, S.A. (NASDAQ:GRFS – Get Rating) was the target of a large drop in short interest in May. As of May 31st, there was short interest totalling 5,140,000 shares, a drop of 10.3% from the May 15th total of 5,730,000 shares. Approximately 2.0% of the shares of the stock are short sold. Based on an […]

Treading on the COVID-19 vaccine opportunity undoubtedly has added a new dimension to our capabilities

Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka. The commercial production in the SML was started in November 1989. Today SML, with a consolidated revenue of R 1,159.76 crore for the year 2021-22 against the previous years’ revenue of Rs 931.27 crore, has emerged as a global brand within manufacturing and supplying of affordable API and Formulation globally in different regulated markets. The Group with over 20 subsidiaries is now setting up a greenfield project located in Karnataka. BioSpectrum India spoke to Vishnukant Bhutada, Managing Director, Shilpa Medicare Limited on the new facility and challenges and growth of the company. Edited excerpts;

Shilpa Medicare Ltd enters Phase I Clinical Trial for its New Biological Entity, recombinant Human Albumin

Shilpa Medicare Ltd enters Phase I Clinical Trial for its New Biological Entity, recombinant Human Albumin
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Human Albumin Market SWOT Analysis, Key Indicators By 2026 |CSL Behring, Grifols, Baxalta, Octapharma, Kedrion, etc – KSU

Human Albumin Market SWOT Analysis, Key Indicators By 2026 |CSL Behring, Grifols, Baxalta, Octapharma, Kedrion, etc – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.